drugset / Trial / NCT02554240

Study to Evaluate the Efficacy and Safety of Intra-articular DA-5202 in Patients With Osteoarthritis of the Knee

NCT02554240 ↗

Phase 2 Completed 115 enrolled Dong-A ST Co., Ltd.
RandomizedParallel-groupDouble-blindTreatment

Summary

This Phase II clinical study is to evaluate the efficacy and safety of DA-5202 in patients with osteoarthritis of the knee.

Timeline

Start
2014-12-23
Primary completion
2016-06-29
Completion
2016-10-14

Drugs

EvaluationDrugModalityDoseRoute
Subject DA-5202 Unknown 10 mg Other
Subject DA-5202 Unknown 20 mg Other
Comparator Na Hyaluronate Unknown 20 mg Other

Indications